Acquisition Backing Innovative Science Solutions was acquired by Cello Health in August 2019 for 10.5 million, signaling a strong validation of its capabilities and potential for access to broader healthcare and pharmaceutical channels through the parent company.

Regulatory Expertise The company specializes in regulatory strategy, FDA submissions, advisory committee reviews, and Rx to OTC switches, presenting an opportunity to upsell to firms seeking end-to-end regulatory support and accelerated market access.

Legal and Compliance Focus With services spanning scientific litigation support and evidence-based substantiations for dietary supplements and foods, there is a clear cross-sell path to legal firms and regulated product manufacturers requiring robust scientific evidence.

Growing Market Position Operating in a space with large IN/CI players and a modest team size (11-50 employees) suggests high value per engagement and potential for expanded regulatory consulting services as client demand increases.

Cross-Sell Potential Tech stack including HubSpot, Mailchimp, and WordPress indicates readiness for targeted marketing, while the affiliation with a larger parent company opens doors to broader industry networks and cross-sell across pharma, medical devices, and dietary supplement sectors.